How Has the Transcatheter Aortic Valve Replacement Market Size Evolved in Recent Years?
The transcatheter aortic valve replacement market has seen considerable growth due to a variety of factors.
•In recent years, the market size for transcatheter aortic valve replacement has seen quick expansion. It's predicted to increase from $5.19 billion in 2024 to $5.91 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%.
The growth experienced in the historic period is credited to factors such as the increasing occurrences of aortic regurgitation, a rise in cardiovascular diseases, a patient trend towards preferring minimally invasive treatments, a worldwide expansion of TAVR procedures, and encouraging reimbursement policies.
What are the Market Size and Expected Growth Rates for the Transcatheter Aortic Valve Replacement Market?
The transcatheter aortic valve replacement market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, significant expansion is anticipated in the transcatheter aortic valve replacement market, predicted to soar to $9.97 billion by 2029 at a compound annual growth rate (CAGR) of 14.0%.
The projected climb during this period can be linked to the escalating incidence of aortic stenosis, increasing acceptance of minimally invasive procedures, broadening of indications for TAVR implementations, advantageous compensation plans, and heightened awareness of TAVR as an effective treatment option. Noteworthy trends emerging in the forecast period consist of the ongoing advancement in device technology, escalating occurrences of cardiovascular diseases, worldwide proliferation of TAVR implementations, maturing population demographic, and growing investment in healthcare.
Which Key Drivers Are Propelling The Transcatheter Aortic Valve Replacement Market's Growth?
An upsurge in cases of aortic stenosis is contributing significantly to the growth of the market for transcatheter aortic valve replacement. Aortic stenosis pertains to the heart's aortic valve narrowing, a health condition that can be addressed through transcatheter aortic valve replacement (TAVR). This procedure is a less invasive substitute for surgical aortic valve replacement (SAVR) that aids in revitalizing blood flow and mitigating the indications and symptoms of aortic valve stenosis. To illustrate, as of May 2024, the American Heart Association, a nonprofit organization based in the US, disclosed that over 12% of older Americans suffer from aortic stenosis, an ailment predominantly seen in individuals above the age of 65. If neglected, this condition could lead to heart failure and may even be life-threatening. Furthermore, in March 2023, a report by the National Institute for Health and Care Excellence (NICE), a public entity in the UK, made known that nearly 1.5% of individuals above 55 in the UK, amounting to about 300,000, are dealing with severe aortic stenosis. Just under 200,000 of these people exhibit symptomatic disease that necessitates treatment, leading to more than 380,000 people on cardiac waiting lists as of March 2023. Consequently, the escalating incidence of aortic stenosis is fueling the market for transcatheter aortic valve replacement.
What Are The Key Segments Within The Global Transcatheter Aortic Valve Replacement Market?
The transcatheter aortic valve replacement market covered in this report is segmented –
1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems
Pre-Book The Transcatheter Aortic Valve Replacement Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Transcatheter Aortic Valve Replacement Market?
In the transcatheter aortic valve replacement (TAVR) sector, product innovation is emerging as a major trend. Firms in this industry are honing their focus on creating groundbreaking and inventive solutions to solidify their market standing. As an illustration, Edwards Lifesciences, a medical technology enterprise based in the US, introduced the Sapien 3 Ultra Resilia valve to the European market in May 2024. This marks the only TAVR system that employs their unique Resilia tissue technology. The advanced technology, tailored to boost the lifespan of the valve, is implemented by using bovine pericardial tissue treated with anti-calcification procedures. By integrating this technology that blocks calcium, the Resilia platform serves to lessen structural valve degradation, a prime reason for reintervention post valve replacement.
Who Are the Key Players in the Transcatheter Aortic Valve Replacement Market?
Major companies operating in the transcatheter aortic valve replacement market include:
• Abbott Laboratories Inc.
• Medtronic plc
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• LivaNova PLC
• Meril Life Sciences Pvt. Ltd.
• Venus MedTech HangZhou Inc
• Braile Biomedica
• Peijia Medical Limited
• Direct Flow Medical Inc.
• Transcatheter Technologies GmbH
• Symetis SA
• JenaValve Technology Inc.
• Micro Interventional Devices Inc.
• Xeltis BV
• Tendyne Holdings Inc.
• MVRx Inc.
• Keystone Heart Ltd.
• Colibri Heart Valve LLC
• HighLife SAS
• Neovasc Inc.
• Aegis Surgical Limited
• Foldax Inc.
• MValve Technologies Ltd.
• NaviGate Cardiac Structures Inc.
What are the Regional Insights into the Transcatheter Aortic Valve Replacement Market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
